(Q35681178)

9 August 2017

title

Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents (English)

1 reference

9 August 2017

Renee E Robinson

1

1 reference

9 August 2017

Milap C Nahata

2

1 reference

9 August 2017

John R Hayes

3

1 reference

9 August 2017

Donald L Batisky

4

1 reference

9 August 2017

Carlton M Bates

5

1 reference

9 August 2017

John D Mahan

6

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

24

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

195-197

1 reference

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

Osteoporosis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

Genetic heterogeneity in osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

Hypercalcaemia in osteogenesis imperfecta treated with pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

The interaction of patient perception of overmedication with drug compliance and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.2.195.33143

10.1592/PHCO.24.2.195.33143

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference